Dynamics of IgG seroconversion and pathophysiology of COVID-19 infections
We report dynamics of seroconversion to SARS-CoV-2 infections detected by IgG ELISA in
177 individuals diagnosed by RT-PCR. Longitudinal analysis identifies 2-8.5% of individuals …
177 individuals diagnosed by RT-PCR. Longitudinal analysis identifies 2-8.5% of individuals …
[HTML][HTML] IgG seroconversion and pathophysiology in severe acute respiratory syndrome coronavirus 2 infection
…, Y Augustin, RL Byrne, M Cocozza… - Emerging infectious …, 2021 - ncbi.nlm.nih.gov
We investigated the dynamics of seroconversion in severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection. During March 29–May 22, 2020, we collected serum …
coronavirus 2 (SARS-CoV-2) infection. During March 29–May 22, 2020, we collected serum …
Rapid development of COVID-19 rapid diagnostics for low resource settings: accelerating delivery through transparency, responsiveness, and open collaboration
Here we describe an open and transparent consortium for the rapid development of COVID-19
rapid diagnostics tests. We report diagnostic accuracy data on the Mologic manufactured …
rapid diagnostics tests. We report diagnostic accuracy data on the Mologic manufactured …
[HTML][HTML] Laboratory Evaluation and Field Testing of Dengue NS1 and IgM/IgG Rapid Diagnostic Tests in an Epidemic Context in Senegal
…, K Woolston, A Gaye, C Loucoubar, M Cocozza… - Viruses, 2023 - mdpi.com
In Senegal, the burden of dengue is increasing and expanding. As case management and
traditional diagnostic techniques can be difficult to implement, rapid diagnostic tests (RDTs) …
traditional diagnostic techniques can be difficult to implement, rapid diagnostic tests (RDTs) …
Accuracy of the Mologic COVID-19 rapid antigen test: a prospective multi-centre analytical and clinical evaluation
…, R Byrne, K Buist, DJ Clark, M Cocozza… - Wellcome Open …, 2021 - archive.lstmed.ac.uk
Background: The coronavirus disease 2019 (COVID-19) pandemic has highlighted the reliance
on antigen detection rapid diagnostic tests (Ag-RDTs). Their evaluation at point of use is …
on antigen detection rapid diagnostic tests (Ag-RDTs). Their evaluation at point of use is …
Improvement in long-COVID symptoms using acupuncture: a case study
M Hollifield, K Cocozza, T Calloway, J Lai… - Medical …, 2022 - liebertpub.com
Background: The long-COVID syndrome (LCS), defined by residual symptoms from acute
COVID-19 for <60 days, affects about one-third of all COVID survivors and is an emerging …
COVID-19 for <60 days, affects about one-third of all COVID survivors and is an emerging …
A phase 2 multicenter study of ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody, in patients with relapsing forms of multiple sclerosis
…, Y Liu, M Petracca, S Cocozza… - Multiple Sclerosis …, 2021 - journals.sagepub.com
Background: Ublituximab, a novel monoclonal antibody (mAb) targeting a unique epitope
on the CD20 antigen, is glycoengineered for enhanced B-cell targeting through antibody-…
on the CD20 antigen, is glycoengineered for enhanced B-cell targeting through antibody-…
[HTML][HTML] Tractography dissection variability: What happens when 42 groups dissect 14 white matter bundles on the same dataset?
White matter bundle segmentation using diffusion MRI fiber tractography has become the
method of choice to identify white matter fiber pathways in vivo in human brains. However, like …
method of choice to identify white matter fiber pathways in vivo in human brains. However, like …
Extracellular vesicles and co‐isolated endogenous retroviruses from murine cancer cells differentially affect dendritic cells
F Cocozza, L Martin‐Jaular, L Lippens… - The EMBO …, 2023 - embopress.org
Cells secrete extracellular vesicles (EVs) and non‐vesicular extracellular (nano)particles (NVEPs
or ENPs) that may play a role in intercellular communication. Tumor‐derived EVs have …
or ENPs) that may play a role in intercellular communication. Tumor‐derived EVs have …
Final MRI Results At 6 Months From A Phase 2 Multicenter Study Of Ublituximab, A Novel Glycoengineered Anti-CD20 Monoclonal Antibody (mAb), In Patients With …
Objective: To examine the effect of ublituximab on the development of new gadolinium (Gd)
enhancing lesions, T2 lesions and T1 hypointense volume at Week 24 in RMS subjects. …
enhancing lesions, T2 lesions and T1 hypointense volume at Week 24 in RMS subjects. …
